| Guidelines for validation of next-generation sequencing–based oncology panels: a joint consensus recommendation of the Association for Molecular Pathology and College of … LJ Jennings, ME Arcila, C Corless, S Kamel-Reid, IM Lubin, J Pfeifer, ... The Journal of molecular diagnostics 19 (3), 341-365, 2017 | 636 | 2017 |
| Assuring the quality of next-generation sequencing in clinical laboratory practice AS Gargis, L Kalman, MW Berry, DP Bick, DP Dimmock, T Hambuch, F Lu, ... Nature biotechnology 30 (11), 1033-1036, 2012 | 503 | 2012 |
| Relevance, pathogenesis, and testing algorithm for mismatch repair–defective colorectal carcinomas: a report of the association for molecular pathology WK Funkhouser Jr, IM Lubin, FA Monzon, BA Zehnbauer, JP Evans, ... The Journal of Molecular Diagnostics 14 (2), 91-103, 2012 | 223 | 2012 |
| Residues 484-508 Contain a Major Determinant of the Inhibitory Epitope in the A2 Domain of Human Factor VIII∗ JF Healey, IM Lubin, H Nakai, EL Saenko, LW Hoyer, D Scandella, ... Journal of Biological Chemistry 270 (24), 14505-14509, 1995 | 187 | 1995 |
| Good laboratory practice for clinical next-generation sequencing informatics pipelines AS Gargis, L Kalman, DP Bick, C Da Silva, DP Dimmock, BH Funke, ... Nature biotechnology 33 (7), 689-693, 2015 | 164 | 2015 |
| Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology I Schrijver, N Aziz, DH Farkas, M Furtado, AF Gonzalez, TC Greiner, ... The Journal of Molecular Diagnostics 14 (6), 525-540, 2012 | 152 | 2012 |
| Residues Glu2181-Val2243 contain a major determinant of the inhibitory epitope in the C2 domain of human factor VIII JF Healey, RT Barrow, HM Tamim, IM Lubin, M Shima, D Scandella, ... Blood, The Journal of the American Society of Hematology 92 (10), 3701-3709, 1998 | 131 | 1998 |
| Assuring the quality of next-generation sequencing in clinical microbiology and public health laboratories AS Gargis, L Kalman, IM Lubin Journal of clinical microbiology 54 (12), 2857-2865, 2016 | 129 | 2016 |
| The cDNA and derived amino acid sequence of porcine factor VIII JF Healey, IM Lubin, P Lollar | 104 | 1996 |
| Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting CA Bellcross, SR Bedrosian, E Daniels, D Duquette, H Hampel, ... Genetics in medicine 14 (1), 152-162, 2012 | 103 | 2012 |
| Attitudes of clinicians following large-scale pharmacogenomics implementation JF Peterson, JR Field, Y Shi, JS Schildcrout, JC Denny, TL McGregor, ... The pharmacogenomics journal 16 (4), 393-398, 2016 | 86 | 2016 |
| Reporting incidental findings in genomic scale clinical sequencing—a clinical laboratory perspective: a report of the Association for Molecular Pathology M Hegde, S Bale, P Bayrak-Toydemir, J Gibson, LJB Jeng, L Joseph, ... The Journal of Molecular Diagnostics 17 (2), 107-117, 2015 | 74 | 2015 |
| Public health impact of genetic tests at the end of the 20th century PW Yoon, B Chen, A Faucett, M Clyne, M Gwinn, IM Lubin, W Burke, ... Genetics in Medicine 3 (6), 405-410, 2001 | 71 | 2001 |
| Analysis of the human factor VIII A2 inhibitor epitope by alanine scanning mutagenesis IM Lubin, JF Healey, RT Barrow, D Scandella, P Lollar Journal of Biological Chemistry 272 (48), 30191-30195, 1997 | 71 | 1997 |
| Elimination of a major inhibitor epitope in factor VIII. IM Lubin, JF Healey, D Scandella, MS Runge, P Lollar Journal of Biological Chemistry 269 (12), 8639-8641, 1994 | 68 | 1994 |
| Clinician perspectives about molecular genetic testing for heritable conditions and development of a clinician-friendly laboratory report IM Lubin, MM McGovern, Z Gibson, SJ Gross, E Lyon, RA Pagon, VM Pratt, ... The Journal of Molecular Diagnostics 11 (2), 162-171, 2009 | 60 | 2009 |
| Developing a sustainable process to provide quality control materials for genetic testing B Chen, C D O'Connell, DJ Boone, JA Amos, JC Beck, MM Chan, ... Genetics in Medicine 7 (8), 534-549, 2005 | 54 | 2005 |
| Current landscape and new paradigms of proficiency testing and external quality assessment for molecular genetics LV Kalman, IM Lubin, S Barker, D Du Sart, R Elles, WW Grody, M Pazzagli, ... Archives of Pathology and Laboratory Medicine 137 (7), 983-988, 2013 | 47 | 2013 |
| Newborn screening: from Guthrie to whole genome sequencing M Caggana, EA Jones, SI Shahied, S Tanksley, CA Hermerath, IM Lubin Public Health Reports 128 (2_suppl), 14-19, 2013 | 42 | 2013 |
| Quality assurance in human molecular genetics testing: status and recommendations LO Williams, EC Cole, IM Lubin, NI Iglesias, RL Jordan, LE Elliott Archives of pathology & laboratory medicine 127 (10), 1353-1358, 2003 | 40 | 2003 |
